Argutus Medical Ltd. is the world leader in developing and manufacturing novel organ injury tests. We specialize in detecting early, acute injury to the kidney, liver and pancreas. For over 10 years, our expert, dedicated team of professionals have pioneered the discovery and development of these valuable tests for use in rat and man. These easy-to-use microtitre plate assay kits have particular application in assessing the safety and effectiveness of drug candidates in clinical trials.
Please click our company profile video below to view a short presentation on our company, our products and how we are making a mark in medicine.
Stemming from rapid sales growth as the biomarkers division in Biotrin International, Argutus was formed in July 2009 as a spin out to give enhanced focus on expanding its portfolio of test. Argutus prides itself on:
- Extensive experience in the development of high quality, user friendly laboratory tests
- Collaborating with global partners to deliver our products in the right format for your laboratory
- Working with key industry consortia (ILSI/HESI & SAFE-T IMI) to qualify preclinical and clinical biomarkers for regulatory approval
Please click below to view our company brochure
